![Andres Gomez: Venetoclax can be effectively reduced to 100 mg when combined with azoles in a first-line, phase 2 trial done under limited resources.](https://oncodaily.com/pub/uploads/2023/08/Andres-Gomez-e1693350922976-1280x1077.jpg)
Photo from Andres Gomez/Twitter
Aug 29, 2023, 19:15
Andres Gomez: Venetoclax can be effectively reduced to 100 mg when combined with azoles in a first-line, phase 2 trial done under limited resources.
Andres Gomez, an Associate Professor at Universidad Autónoma de Nuevo León, Mexico, recently tweeted:
“Venetoclax is an expensive life-saving drug in AML. We have proven it can be effectively reduced to 100 mg when combined with azoles in a first-line, phase 2 trial done under limited resources.
Out now in Leuk Res, access here:”
Source: Andres Gomez/Twitter
Jul 4, 2024, 00:09